Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer
2021 · Cell Death and Disease · 54 citations
https://doi.org/10.1038/s41419-021-04118-4
Y
Yingke Zhou
Union Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
611
Citations
14
h-index
14
i10-index
Yingke Zhou is an academic researcher from Union Hospital. The author has contributed to research in topics: Histone Deacetylase Inhibitors Research & Epigenetics and DNA Methylation & Cancer, Lipids, and Metabolism. The author has an h-index of 14, co-authored 29 publications.
ORCID: 0000-0001-9632-2597Papers by this author
worksNR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15
2021 · Cell Death Discovery · 24 citations
https://doi.org/10.1038/s41420-021-00462-8
Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis
2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 6 citations
https://doi.org/10.1016/j.bbadis.2024.167183
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat